Ruibo (Suzhou) Pharmaceutical Co., Ltd. announced that it has received CNY 560,000,000 in a round of funding on April 27, 2023. The transaction included participation from returning investor, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. The transaction has been approved in the 29th meeting of the 7th directorate and the 22nd meeting of the 7th supervisory board of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Recently, the company has completed the change of business registration of its capital increase.